J.R. Simplot implements gene editing technology to extend shelf life
Gene editing technology like CRISPR-Cas9 genome editing tools may be able to significantly increase shelf life of avocados, strawberries and other fruits.
The J.R. Simplot Co., Boise, Idaho, executed a joint intellectual property licensing agreement with Corteva Agriscience, the Indianapolis, Ind., agriculture division of DowDuPont, the Broad Institute of MIT, Cambridge, Mass., and Harvard University, Cambridge, Mass., for foundational CRISPR-Cas9 and related gene editing tools. The technology provides Simplot with another avenue to bring desirable traits forward in certain fruits and vegetables and advance products to the market in the United States.
Gene editing technology like CRISPR-Cas9 genome editing tools may be able to significantly increase shelf life of avocados, strawberries and other fruits.
"We're excited to add CRISPR-Cas9 technology to our platform of tools aimed at providing more sustainable produce for the industry," says Susan Collinge, vice president of Simplot plant sciences. "These pioneering tools may enable growers to achieve higher yields on less land, resulting in fewer pesticides, water and labor needs while extending the quality of a consumer's favorite foods."
Comprehensive intellectual property rights allow entities to apply scientific tools as widely as possible. To enable such access, Corteva Agriscience and Broad Institute agreed on a joint non-exclusive licensing framework for agricultural use. The license to Simplot represents the first time that Corteva Agriscience and Broad Institute have jointly provided a license of CRISPR-Cas9 genome editing tools to an agricultural company.
"We applaud Simplot for taking the initiative to broaden their portfolio of food technologies to further enhance sustainability and reduce food waste," says Neal Gutterson, chief technology officer at Corteva Agriscience. "CRISPR-Cas9 offers farmers and consumers so many great benefits. It's exciting to see a company with such a strong innovation track record putting CRISPR-Cas9 to work."
"Our goal is to maximize the scientific impact of CRISPR-Cas9 for improving agriculture, and our joint licensing agreement offers the opportunity to provide much broader access to help researchers reduce food waste, limit pesticides and improve drought resistance, while promoting safe and ethical uses of groundbreaking technologies," says Issi Rozen, chief business officer of the Broad Institute.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
